On 28-29 March 2019, leaders from across the field of microbiome therapeutics will gathering in Vienna to discuss the latest research, developments and discoveries in the pursuit to translate the power of the human microbiome into commercially viable medicines.
Over 2 days, Microbiome Therapeutics Europe will explore the ins and outs of emerging technologies, learnings from clinical trials, regulatory hurdles and commercial challenges to help you gain the information and connections you need to take your pipeline to the next level.
Book now and secure your place alongside the likes of AOBiome, AMC Amsterdam, Merck, Eligo Bioscience, The BioCollective, BioMarketing Insight, Evolve Biosystems Inc. and more to gain practical industry insights, and discuss manufacturing and formulation strategies to take these projects from concepts to market.
Plus, stay up-to-date of the regulatory framework developments and seek out investment opportunities to ensure you’re equipped with the information you need for your products to succeed.
LISAvienna will attend the conference. Contact us in advance to arrange a meeting and learn more about Vienna's life science community and the 360-degree support for start-ups!